ClinicalTrials.Veeva

Menu

Effects of Lower Body EMS Training in Postmenopausal Women (LB-EMS-PMW)

S

Seoul National University

Status

Enrolling

Conditions

Postmenopausal Women
Arterial Stiffness, Blood Pressure
Arteriosclerosis
Sarcopenia

Treatments

Device: Lower-body Electromyostimulation (LB-EMS) device
Behavioral: Lower Body Resistance Training

Study type

Interventional

Funder types

Other

Identifiers

NCT07385534
IRB No. 2601/002-017

Details and patient eligibility

About

This study evaluates the effects of a 6-week lower body Electrical Muscle Stimulation (EMS) training program on body composition, muscle function, and arteriosclerosis markers in postmenopausal women.

Menopause is associated with a rapid decline in estrogen, which increases the risk of sarcopenia (muscle loss) and arterial stiffness (cardiovascular disease). While resistance training is effective for these conditions, participation rates among postmenopausal women are often low. This study investigates whether applying EMS during lower body resistance exercises provides superior benefits compared to resistance training alone or no intervention.

Participants will be randomized into three groups:

  1. Lower-body EMS combined with Resistance Training Group
  2. Resistance Training Only Group
  3. Control Group (No intervention)

The study aims to verify the efficacy of EMS as a time-efficient and effective alternative exercise modality for improving vascular and musculoskeletal health in this population.

Enrollment

39 estimated patients

Sex

Female

Ages

50 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Post-menopausal women (defined as cessation of menstruation for at least 12 months).
  • Aged between 50 and 70 years.
  • Sedentary lifestyle (no participation in regular resistance training programs within the last 6 months).
  • Able to perform lower body resistance exercise with LB-EMS suit.
  • Willing to participate in the study and provide informed consent.

Exclusion criteria

  • Contraindications for WB-EMS: Presence of implanted electrical devices (e.g., pacemakers, defibrillators), severe bleeding disorders (e.g., hemophilia), abdominal/inguinal hernia, or history of surgery within the last 6 months (including stent insertion).
  • Severe Chronic Diseases: Diagnosis of severe cardiovascular (e.g., MI, heart failure, arrhythmia), renal, neurological (e.g., epilepsy), or oncological diseases (currently undergoing treatment).
  • Uncontrolled Cardiovascular Conditions: Uncontrolled hypertension or severe arterial circulatory disorders.
  • Confounding Medications: Current use of hormone replacement therapy (HRT) for menopause or medications for severe psychiatric disorders (e.g., depression, anxiety).
  • Acute Conditions & Others: Acute infection/inflammation, influence of alcohol/drugs, or any other condition deemed unsuitable by the investigator.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

39 participants in 3 patient groups

Lower Body EMS + Resistance Training Group
Experimental group
Description:
Participants perform lower body resistance training while wearing a lower body EMS suit. Each session lasts 50 minutes (10-min warm-up, 30-min main exercise, 10-min cool-down). EMS stimulation is applied exclusively during the 30-minute main exercise phase (85Hz, 350µs). This program is conducted twice a week for 6 weeks.
Treatment:
Behavioral: Lower Body Resistance Training
Device: Lower-body Electromyostimulation (LB-EMS) device
Resistance Training Only Group
Active Comparator group
Description:
Participants perform the identical lower body resistance training program without EMS stimulation. The session structure (10-min warm-up, 30-min main exercise, 10-min cool-down) and total duration (50 minutes) are the same as the experimental group.
Treatment:
Behavioral: Lower Body Resistance Training
Control Group
No Intervention group
Description:
Participants maintain their usual daily lifestyle without engaging in any new exercise programs during the 6-week study period.

Trial contacts and locations

1

Loading...

Central trial contact

Kyungho Kim, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems